GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareMax Inc (NAS:CMAX) » Definitions » Intrinsic Value: Projected FCF

CareMax (CareMax) Intrinsic Value: Projected FCF : $0.00 (As of May. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is CareMax Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-24), CareMax's Intrinsic Value: Projected FCF is $0.00. The stock price of CareMax is $2.89. Therefore, CareMax's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for CareMax's Intrinsic Value: Projected FCF or its related term are showing as below:

CMAX's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.295
* Ranked among companies with meaningful Price-to-Projected-FCF only.

CareMax Intrinsic Value: Projected FCF Historical Data

The historical data trend for CareMax's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareMax Intrinsic Value: Projected FCF Chart

CareMax Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
- - - -

CareMax Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CareMax's Intrinsic Value: Projected FCF

For the Health Information Services subindustry, CareMax's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CareMax's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CareMax's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where CareMax's Price-to-Projected-FCF falls into.



CareMax Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



CareMax  (NAS:CMAX) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

CareMax's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=2.89/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CareMax Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of CareMax's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


CareMax (CareMax) Business Description

Traded in Other Exchanges
N/A
Address
1000 NW 57th Court, Suite 400, Miami, FL, USA, 33126
CareMax Inc is a technology-enabled care platform providing value-based care and chronic disease management to seniors. It operates various owned medical centers that offer a comprehensive suite of healthcare and social services and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.
Executives
Bryan Cho director 30 HUDSON YARDS, 72ND FLOOR, NEW YORK NY 10001
De La Torre Ralph director, 10 percent owner 4939 BROOKVIEW DRIVE, DALLAS TX 75220
Ryan Oquinn director 1000 NW 57 COURT, SUITE 400, MIAMI FL 33126
Kevin Berg director 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Beatriz Maria Assapimonwait director 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Vincent Omachonu director 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Jose Ramon Rodriguez director PRIMORIS SERVICES CORPORATION, 2300 NORTH FIELD STREET, SUITE 1900, DALLAS TX 75201
Related Cm Advisor, Llc director 30 HUDSON YARDS, 72ND FLOOR, NEW YORK NY 10001
Imc Holdings, Lp 10 percent owner 525 OKEECHOBEE BOULEVARD, SUITE 1050, WEST PALM BEACH FL 33401
William C. Lamoreaux officer: EVP 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Kevin Wirges officer: EVP, Treasurer and CFO 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
De Solo Carlos A. director, officer: President and CEO 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Randy Simpson director C/O GLENVIEW CAPITAL MANAGEMENT, LLC, 767 FIFTH AVENUE, 44TH FLOOR, NEW YORK NY 10153
Solo Alberto De officer: EVP and COO 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Jennifer L. Carter director C/O DFP SPONSOR LLC, 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017